Mat Grass Allergy: The Rarest US Grass Allergen With a European Upland Heartland
Mat grass (Nardus stricta) is a Pooideae cool-season grass extremely rare in the United States but dominant across Scottish moorlands, Alpine meadows, and Scandinavian heaths. No WHO/IUIS-named allergens exist for mat grass. Allergenic potential is inferred entirely from Pooideae subfamily classification. If mat grass sensitization occurs, standard timothy-based immunotherapy covers it through Pooideae Group 1 and Group 5 cross-reactivity. This page exists for travelers, immigrants, and the curious.
Free · 5 min · Insurance accepted
Key facts
No WHO/IUIS allergens have been named for mat grass (Nardus stricta) — allergenic potential is inferred from its Pooideae subfamily membership and shared Group 1 and Group 5 cross-reactive proteins with Timothy.
Mat grass is essentially absent from North America but dominates over 15 countries of European moorland, Alpine meadow, and Scandinavian heath — making it a relevant allergen primarily for European travelers or immigrants.
Timothy grass allergen immunotherapy provides complete cross-reactive coverage for all Pooideae grasses including mat grass through shared Phl p 1 (Group 1) and Phl p 5 (Group 5) protein families.
North American Pooideae grass pollen seasons have started approximately 20 days earlier since 1990 with 21% increased pollen concentration — trends relevant to all cross-reactive Pooideae species including mat grass.
What Is Mat Grass Allergy?
Mat grass allergy is an immune reaction to pollen from Nardus stricta, a tough, wiry perennial grass of acidic, nutrient-poor soils that forms dense, low mats on moorlands and mountain grasslands — giving rise to its common name.
Nardus stricta belongs to subfamily Pooideae and is therefore expected to share Group 1 and Group 5 allergens with timothy, ryegrass, and other sweet grasses, creating cross-reactive sensitization that would respond to standard Pooideae immunotherapy.
Mat grass is, by most measures, the least clinically relevant grass allergen for US patients. It is very rare in the United States — limited to small populations in northeastern states — and has virtually no published US allergology research. The research file rates it as very sparse data quality. No WHO/IUIS-named allergens have been identified, no commercial pollen extract exists for clinical use, and US allergists encounter it essentially never as a primary sensitization driver.
The primary clinical relevance of this page is for three patient populations: travelers who have spent extended time in the European highland environments where mat grass dominates (Scottish moors, Alpine meadows, Scandinavian heaths); recent immigrants from these regions; and patients who have encountered the term on a test result or internet search and need clear, honest information about what mat grass allergy actually means for their diagnosis and treatment.
Mat Grass Allergy Symptoms
Recognizing symptoms early helps you get the right treatment faster.
Sneezing and rhinorrhea
mildBilateral sneezing and watery nasal discharge from mat grass pollen inhalation. Typical of Pooideae sensitization; symptoms onset rapidly after exposure in moorland or alpine environments.
Nasal congestion
mildTurbinate swelling causing bilateral nasal obstruction during peak mat grass exposure in European highland environments during June–August.
Ocular itching and tearing
mildConjunctival pruritus, redness, and increased lacrimation from airborne mat grass pollen contact. Worsens with rubbing and with sustained outdoor exposure in Nardus-dominated landscapes.
Itchy throat and palate
mildPosterior pharyngeal and soft palate pruritus from pollen settling on mucosal surfaces during outdoor time in mat grass moorland environments.
Allergic conjunctivitis
mildPeriorbital swelling and photophobia beyond basic ocular itching. May be pronounced in open moorland environments with wind-driven pollen concentration.
Asthma exacerbation
moderateIn sensitized asthmatic patients, mat grass pollen in highland environments can precipitate bronchospasm. The open, wind-swept moorland habitat may concentrate pollen at high levels on dry, warm days.
Fatigue
mildPersistent nasal inflammation and disrupted sleep during multi-week highland travel or residence during the mat grass pollen season contributes to systemic fatigue.
When to see a doctor
Mat grass allergy symptoms would be characteristic of Pooideae grass pollen allergic rhinoconjunctivitis — clinically indistinguishable from symptoms caused by timothy, ryegrass, or Kentucky bluegrass allergy. Because mat grass carries the same Group 1 and Group 5 allergen framework as other sweet grasses, the immune response it triggers is the same in terms of mediators, tissue targets, and clinical presentation. Patients exposed to mat grass in European highland environments would experience sneezing, watery nasal discharge, itchy and watery eyes, nasal congestion, and in asthmatic patients, potential bronchospasm — following the standard Pooideae grass allergy pattern. The geographic and temporal context distinguishes mat grass from other grass allergies: symptoms specifically during summer hiking or travel in European moorland and mountain environments would be the distinguishing clinical clue. For the rare US patient with documented mat grass sensitization, symptoms during June through August from the northeastern US populations would be indistinguishable from reactions to the far more prevalent Pooideae grasses in the same region. Seek emergency care if you develop sudden severe breathing difficulty, throat closure, or widespread hives — though anaphylaxis from grass pollen allergy is exceedingly rare.
Mat Grass Pollen and Asthma
Mat grass, as a Pooideae grass, shares the asthma trigger potential of other sweet grasses. For asthmatic patients who travel or reside in European highland regions during the June–August season, mat grass pollen represents the same class of bronchial trigger as timothy or ryegrass. Open moorland and alpine meadow environments can generate high airborne pollen concentrations on dry, warm days with wind — conditions that maximize respiratory exposure. For US patients with Pooideae-driven asthma planning highland European travel, packing controller medications and a rescue bronchodilator is strongly advisable before entering environments where Nardus moorland is extensive. The cross-reactive Pooideae sensitization that drives US grass asthma from timothy and ryegrass will also respond to mat grass pollen in European environments. Pre-travel consultation with an allergist to ensure asthma medications are optimized before highland European trips is worthwhile for sensitized patients.
Complications of Mat Grass Allergy
Mat grass allergy complications in the US context are minimal given the near-absence of the plant from North American landscapes. The primary complication risk would arise for US patients traveling or residing in European highland environments during the June–August pollen season without adequate medication preparation.
Unprepared travel to European highlands
Pooideae-sensitized US patients traveling to Scottish moors, Alpine meadows, or Scandinavian heaths during June–August without allergy medications may experience significant rhinitis and asthma symptoms in environments with dense Nardus grassland.
Misidentification as a primary US allergen
If a patient presents with mat grass-specific IgE on a broad panel without European exposure history, this may represent Pooideae cross-reactive sensitization driven by more prevalent US Pooideae grasses rather than true mat grass-specific allergy.
Unnecessary avoidance anxiety
Patients who receive a mat grass allergy result without context may unnecessarily restrict outdoor activities based on a sensitization with essentially zero practical US exposure risk.
What Causes Mat Grass Allergy?
Mat grass allergy would be caused by IgE sensitization to windborne pollen from Nardus stricta, a wiry cool-season perennial grass that pollinates from June through August. Because mat grass is so rare in the United States, meaningful sensitization would almost exclusively occur through exposure in European highland environments — the Scottish Highlands, Pennines, Welsh uplands, Alps, Carpathians, Apennines, and Scandinavian mountains where Nardus stricta dominates extensive moorland communities that cover millions of hectares.
Mat grass / matgrass / nard
Nardus stricta
Timothy grass (Pooideae reference for cross-reactive sensitization and testing)
Phleum pratense
How it works
Mat grass sensitization would follow Type I IgE-mediated hypersensitivity identical in mechanism to all Pooideae grass allergies. The expected allergen proteins are Group 1 (beta-expansin) and Group 5 (ribonuclease-like) homologs — the same protein families driving greater than 95% Pooideae cross-reactivity across timothy, ryegrass, bentgrass, and related species. On sensitization, grass-specific IgE binds to mast cells and basophils, triggering degranulation with histamine and leukotriene release upon subsequent pollen exposure. The mechanism is identical to any other Pooideae grass allergy; the only distinctiveness is the geographic rarity of the exposure source.
In Europe, mat grass moorland (Nardetum) is one of the most widespread upland plant communities, often forming near-monocultures on acidic soils from sea level to alpine zones. Hikers, sheep farmers, ecologists, and outdoor recreation enthusiasts in these environments during June through August face meaningful mat grass pollen exposure during the main Pooideae grass season.
For US patients, the practical pathway to mat grass sensitization is through international travel or immigration from highland European regions. A patient who grew up in Scotland, spent summers hiking in the Alps, or studied ecological field work in Scandinavian heaths may have accumulated mat grass sensitization that would appear as Pooideae cross-reactivity on standard testing.
Risk factors to watch for
Extended time in European highland environments
Hiking, camping, farming, or ecological fieldwork in Scottish moors, Alpine meadows, or Scandinavian heaths during the June–August Nardus pollen season creates meaningful sensitization exposure.
Immigration from European highland regions
Individuals who grew up in regions where mat grass moorland is the dominant landscape — Scotland, Wales, Norway, Austria, Switzerland, northern Spain — may carry mat grass-specific or Pooideae cross-reactive IgE from childhood sensitization.
Existing Pooideae sensitization from other grasses
Any patient sensitized to Pooideae grasses (timothy, ryegrass, bluegrass) would be expected to cross-react with mat grass due to greater than 90% Group 1 allergen sequence homology — mat grass sensitization may be an incidental finding in already Pooideae-sensitized patients.
Atopic family history
Genetic predisposition to atopy increases susceptibility to IgE sensitization to environmental grass pollens, including the Pooideae family to which mat grass belongs.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Mat Grass Allergy
Diagnosing mat grass allergy in a US patient relies on Pooideae representative testing because no dedicated Nardus stricta pollen extract exists for clinical use. Standard timothy component testing — Phl p 1 (Group 1) and Phl p 5 (Group 5) — will identify the Pooideae sensitization that underlies mat grass cross-reactivity. A positive result confirms susceptibility to mat grass pollen based on Pooideae cross-reactive IgE. The clinical context is everything: a US patient with no European highland exposure history who tests positive on a Pooideae panel has grass pollen allergy driven overwhelmingly by more prevalent US species like timothy, ryegrass, and bluegrass, with mat grass cross-reactivity as a theoretical rather than practical finding. A US patient who spent a summer hiking in Scotland and developed hay fever symptoms during that trip has a plausible mat grass exposure history. At-home allergy testing services such as Curex offer Pooideae component panels through a finger-prick blood draw, providing a convenient starting point for patients who want to understand their grass pollen sensitization profile before an allergist visit. Positive Phl p 5 confirms Pooideae sensitization and guides the appropriate immunotherapy pathway — which would be effective for mat grass regardless of geographic exposure history. There is no clinical reason to seek mat grass-specific testing in the United States. The sensitization, if present, is covered by Pooideae evaluation and treated with Pooideae immunotherapy.
Timothy Component IgE (Phl p 1 + Phl p 5)
The standard Pooideae sensitization test. Positive Phl p 5 identifies Pooideae-specific IgE that would cross-react with mat grass and all other sweet grasses. This is the appropriate diagnostic test for any patient concerned about mat grass allergy.
Skin Prick Test — Standard Pooideae Grass Mix
Prick testing with a standard grass panel including timothy and other Pooideae representatives identifies the sensitization class. Positive wheal of 3mm or greater above saline control confirms cross-reactive sensitization consistent with mat grass allergy.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreating Mat Grass Allergy
See how different approaches stack up for managing your allergy symptoms long-term.
Mat grass allergy treatment is straightforward because mat grass is fully cross-reactive with timothy through Pooideae Group 1 and Group 5 allergen sharing — the entire arsenal of Pooideae immunotherapy options applies without any mat grass-specific formulation.
For US patients, the practical treatment approach is identical to standard timothy grass allergy management. For European travelers with Pooideae sensitization, the treatment approach is also identical — effective Pooideae immunotherapy in the US will provide protection during European highland travel where mat grass is a dominant pollen source.
The simplest message for mat grass-sensitized patients: your allergy is covered by standard grass allergy treatment. You do not need a special extract, a special clinic, or a specially formulated immunotherapy. Everything developed for the common grass pollen allergy that affects millions of Americans applies to you.
Avoidance during European highland travel
For US patients traveling to Scottish moors, Alpine meadows, or Scandinavian heaths during June–August, limiting exposure during warm, dry afternoons when mat grass pollen peaks and carrying allergy medications proactively.
N/A
Partial; complete avoidance is impractical when traveling through Nardus-dominated landscapes
Intranasal corticosteroids
First-line treatment for Pooideae-driven rhinitis including mat grass. Essential for European highland travelers to pack before departure. Begin use 1–2 weeks before travel to Nardus-dominated environments.
Fluticasone (Flonase), mometasone (Nasonex), budesonide (Rhinocort), triamcinolone (Nasacort)
50–70% reduction in rhinitis symptom burden; superior to antihistamines for nasal congestion
Second-generation oral antihistamines
Non-sedating antihistamines control sneezing, ocular itching, and rhinorrhea from mat grass and other Pooideae pollens. Practical carry-along medication for European highland travel.
Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra), levocetirizine (Xyzal)
60–70% improvement in rhinitis scores; most effective for sneezing and itch
Grastek or Oralair SLIT tablets (FDA-approved Pooideae)
FDA-approved sublingual tablets for Pooideae sensitization are appropriate for mat grass allergy given full cross-reactivity. Particularly beneficial for patients with recurrent European highland travel who want to address the underlying sensitization rather than taking medications every trip.
Grastek (timothy 2800 BAU), Oralair (5-grass 300 IR)
Pivotal trials showed 10–34% TCS reduction vs. placebo; 3 consecutive years for sustained post-treatment benefit
Custom SLIT drops — Timothy extract (Pooideae)
Custom-compounded Pooideae SLIT drops covering mat grass through cross-reactivity. Practical for patients co-sensitized to multiple allergens beyond grass alone.
Custom-compounded timothy and/or Pooideae grass SLIT drops
Over 100 controlled trials show 50–75% symptom reduction with SLIT for grass pollen; cross-reactivity ensures mat grass coverage
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for Mat Grass Allergy
Instead of masking symptoms, immunotherapy retrains your immune system.
The immunotherapy story for mat grass allergy is uniquely simple compared to most allergens on this platform: because Nardus stricta is a Pooideae grass, the entire infrastructure of sweet grass immunotherapy applies without modification. There is no need to search for a mat grass-specific product, import European extracts, or identify a specialist who treats Scottish moorland grass allergy. For US patients with Pooideae sensitization who encounter mat grass during European travel, ongoing Pooideae immunotherapy they may already be taking for US grass allergy will provide meaningful protection during highland travels as well — the same IgE desensitization process that reduces timothy reactivity reduces mat grass reactivity simultaneously. Providers like Curex offer personalized Pooideae SLIT drops with plan-specific pricing (https://getcurex.com/learn/curex-pricing) — an accessible entry point for patients who want to address Pooideae sensitization, whether they are managing US grass allergy season, protecting future European highland travel, or simply responding to a positive Pooideae test result. A real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026) found that clinically meaningful symptom improvement rose to 45% of patients by two years, quality-of-life improvement reached 90.7%, adherence exceeded 90%, and no anaphylaxis was reported. The drops are administered at home, daily, under the tongue, without the weekly clinic commitment of traditional allergy shots. For patients with mat grass as their primary concern, the same Pooideae extract that covers timothy, ryegrass, and bentgrass will cover mat grass through shared Group 1 and Group 5 allergen homology.
Confirm Pooideae sensitization
Phl p 1 and Phl p 5 component testing establishes that Pooideae sensitization is present. Positive results confirm that mat grass cross-reactivity is expected and that timothy immunotherapy is the appropriate pathway.
Standard Pooideae SLIT formulation
A board-certified allergist formulates personalized timothy-based sublingual drops targeting the Pooideae sensitization, with dosing appropriate to the patient's IgE level and overall allergic burden.
Daily home administration
Drops are held under the tongue for two minutes daily, year-round. Gradual escalation builds tolerance to Pooideae allergens including mat grass through shared cross-reactive protein structures.
Protection confirmed for European travel
As Pooideae tolerance builds over the first treatment season, European highland travel during June–August becomes progressively more comfortable, with mat grass pollen provoking reduced immune response.
“Grass pollen SLIT clinical trials show 50–75% symptom reduction across Pooideae sensitization; full Pooideae cross-reactivity ensures mat grass is covered within this framework”
Treat your Mat Grass allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Mat Grass Allergy
Living with mat grass allergy in the United States is, frankly, uncomplicated for most patients: the grass is so rare in North America that no meaningful day-to-day exposure occurs. The practical implications of a mat grass allergy result for most US patients are limited to two scenarios. First, if you are a regular European traveler who visits highland regions in summer, mat grass allergy explains symptoms you may have previously dismissed as unusual travel colds. Proper seasonal allergy management for European highland trips — starting medications before departure rather than scrambling to find pharmacies in a remote Scottish glen — dramatically improves the travel experience. Second, if you received a mat grass-positive result on a broad allergy panel without European exposure history, the result most likely reflects Pooideae cross-reactive IgE from your existing US grass pollen sensitization — not a new, separate allergy you need to worry about. The treatment is identical to your existing grass allergy treatment.
Mat grass allergy is a travel allergy for most US patients
If you have never been to Scottish moors, Alpine meadows, or Scandinavian heaths during summer, mat grass is not affecting your daily US allergy burden. The clinical significance is almost entirely in European highland travel contexts.
Your US grass allergy immunotherapy covers mat grass
If you are already on Pooideae immunotherapy for timothy, ryegrass, or bluegrass allergy in the US, your treatment also covers mat grass — no additional formulation or specialist visit is needed for mat grass protection during European travel.
The rarest US grass allergen deserves honest context
Mat grass has very sparse data quality in published allergology literature and is practically absent from US landscapes. A positive test result deserves clinical contextualization, not alarm. Work with your allergist to understand whether the result reflects true exposure or cross-reactive Pooideae sensitization from more prevalent US grasses.
When Does Mat Grass Pollen Season Occur?
Mat grass pollinates from June through August, placing it squarely within the main European and North American Pooideae grass pollen season. In its primary European highland habitat, the season may start later at higher elevations — July or even August in alpine zones above 1,500 meters — when snow melt delays vegetative growth relative to lower-elevation meadows. In the northeastern United States where mat grass has very small populations, the season would mirror other Pooideae grasses in the region: onset in late May to early June with peak production in June and July. However, the near-absence of mat grass from the US landscape means that this timing information is essentially academic for most American patients — there is no meaningful mat grass pollen season in the US equivalent to the timothy or bluegrass season. For European travelers, the practical implication is that hiking in Scottish moorlands, Norwegian mountain heaths, or Alpine grasslands during June through August places them in peak mat grass pollen season. Patients who know they have Pooideae sensitization should carry their seasonal allergy medications when planning highland European travel during this window.
June - August
medium intensity
Reducing Mat Grass Pollen Exposure
Reducing mat grass pollen exposure for US patients primarily involves travel preparation for planned visits to European highland regions where Nardus stricta is dominant. Within the United States, the near-absence of mat grass from North American landscapes means that domestic exposure is negligible for the vast majority of patients. For European highland travelers, the practical approach combines medication readiness with timing awareness. June and July are the peak mat grass pollen months in most European highland regions. If the primary purpose of travel is highland hiking or nature observation — rather than timing specifically around avoiding pollen season — packing a complete seasonal allergy kit and establishing effective medication use before departure is the most practical strategy.
Pack allergy medications before European highland trips
Scottish moors, Alpine meadows, and Scandinavian heaths during June–August are peak mat grass environments. Bring intranasal steroids, antihistamines, and rescue bronchodilator (if asthmatic) before entering these landscapes.
Start intranasal steroids before departure
Beginning intranasal corticosteroid use one to two weeks before European highland travel allows full anti-inflammatory effect to develop before arrival in Nardus-dominated pollen environments.
Plan highland activities for early morning or after rain
Mat grass pollen concentrations peak in warm, dry afternoons. Morning hikes — before 9 a.m. — and activities following rain events minimize acute pollen exposure in open moorland.
Understand the rarity in the US context
If you have never traveled to European highland regions and have a mat grass result on an allergy panel, this likely reflects Pooideae cross-reactivity from more prevalent US grass sensitization rather than mat grass-specific exposure.
Use HEPA filtration in upland accommodation
When staying in highland European locations during the Nardus season, portable HEPA air purifiers in the bedroom reduce ambient pollen and improve sleep quality despite outdoor exposure.
Prognosis for Mat Grass Allergy
Prognosis for mat grass allergy is favorable and essentially identical to the prognosis for any Pooideae grass pollen allergy. Because Nardus stricta is fully cross-reactive with timothy through Pooideae Group 1 and Group 5 allergen sharing, the well-established immunotherapy outcomes for timothy SLIT and SCIT apply directly. For the vast majority of US patients, mat grass allergy has negligible impact on daily life because the plant is essentially absent from the domestic landscape. For patients with European highland travel plans or immigration from Nardus-dominated regions, managing the underlying Pooideae sensitization through standard immunotherapy provides comprehensive protection for both US and European grass pollen exposure simultaneously.
Key takeaways
Mat grass is one of the rarest grass allergens in US clinical practice — virtually all sensitization in American patients would occur through European highland travel or immigration
No WHO/IUIS-named allergens exist for Nardus stricta; allergenic potential is inferred entirely from Pooideae subfamily classification
Standard timothy-based immunotherapy fully covers mat grass through greater than 90% Pooideae Group 1 and Group 5 cross-reactivity
A positive mat grass result in a US patient without European exposure history likely reflects Pooideae cross-reactive IgE from more prevalent domestic grass sensitization
Mat grass is one of those allergens I see almost exclusively in patients who spent years in the UK, Ireland, or Northern Europe before relocating — their sensitization was genuine from moorland exposure, but in the US context Timothy-based treatment covers them perfectly through Pooideae cross-reactivity.
Frequently Asked Questions
No. Mat grass (Nardus stricta) is one of the rarest grass allergens in US clinical practice. The plant has very limited populations restricted to small areas in the northeastern United States, with no meaningful presence in any other region of the country. The published allergology literature rates mat grass as very sparse data quality for the US context, and US allergists encounter it essentially never as a primary sensitization driver. The plant is ecologically dominant in European highland environments — Scottish moorlands, Alpine meadows, Scandinavian heaths — but has not established significant populations in North America. For most US patients, a mat grass allergy result reflects Pooideae cross-reactive IgE from more prevalent domestic grass sensitization rather than actual mat grass exposure.
Medical References
- [1]Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. International Archives of Allergy and Immunology. 2003;130(2):87-107.
- [2]Niederberger V, Laffer S, Fröschl R, et al. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, Bet v 2) account for a high percentage of grass pollen–specific IgE. J Allergy Clin Immunol. 1998;101(2):258-264.
- [3]Anderegg WRL, Abatzoglou JT, Anderegg LDL, et al. Anthropogenic climate change is worsening North American pollen seasons. PNAS. 2021;118(7):e2013284118.
- [4]AAAAI. "Sublingual Immunotherapy Treatment Allergic Rhinitis."
- [5]Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al. EAACI Molecular Allergology User's Guide. Pediatric Allergy and Immunology. 2016;27(Suppl 23):1-250.
- [6]Bielory L, et al. Climate change and allergen exposure: systematic review of 103 studies 2022-2024. JACI In Practice. 2024.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Mat Grass allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.
